Agenus (AGEN) EBT Margin Growth (3y) (2013 - 2026)
Agenus (AGEN) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | 24,198.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24,198.00 |
| Dec 31, 2025 | -13,576.00 |
| Sep 30, 2025 | 16,246.00 |
| Jun 30, 2025 | 9,885.00 |
| Mar 31, 2025 | 3,206.00 |
| Dec 31, 2024 | 9,759.00 |
| Sep 30, 2024 | -32,446.00 |
| Jun 30, 2024 | 94,649.00 |
| Mar 31, 2024 | 15,391.00 |
| Dec 31, 2023 | 6,592.00 |
| Sep 30, 2023 | 15,144.00 |
| Jun 30, 2023 | -3,476.00 |
| Mar 31, 2023 | 2,781.00 |
| Dec 31, 2022 | 18,767.00 |
| Sep 30, 2022 | 923.00 |
| Jun 30, 2022 | 8,394.00 |
| Mar 31, 2022 | -17,175.00 |
| Dec 31, 2021 | 34,354.00 |
| Sep 30, 2021 | 27,119.00 |
| Jun 30, 2021 | -109,604.00 |